LongCovid
Do not miss the chance to learn more about the project’s updates for the past months. You can subscribe now on the contact section of this website.
This review, published by the Lancet, was conducted using the Joanna Briggs Institute (JBI) Methodology for Scoping Reviews. A search was executed in the MEDLINE and EMBASE databases,…
As shown by this Science article, research suggests that the risk of Long COVID symptoms 3 months after infection has dropped: Original strain and Alpha: 46%, Delta: 35%…
Do not miss this opinion article on Long COVID written by Esther K. Choo & Scott Duke Kominers in the Scientific American. “We all wish the pandemic were behind us.…
Very interesting event for our German speaking follower! The German Health Minister Karl_Lauterbach and the ME/ CFS and Long COVID expert Carmen Scheibenbogen talk about Long COVID on 18th of…
On the 19th of April for the COVIRNA Final Conference is taking place in Brussels. Join it to learn more about what is needed for the product development…
Do not miss this very interesting publication with some remarkable findings from ORCHESTRA cohort study on COVID-19 antibodies in vaccinated healthcare workers (HCW). ORCHESTRA cohort investigated changes in…
This morning Long COVID had a very fruitful discussion during its first exploitation workshop held by Steinbeis Europa Zentrum (Communication, dissemination and exploitation leader). During this online event, the consortium…
Do not miss this really interesting article written by Carrie Arnold (Johns Hopkins Bloomberg School of Public Health) on Long COVID’s causes and impacts. The article has just…
Current ventilation rates are not designed for COVID-19 (or any other respiratory pathogen). For that reason, the Lancet COVID-19 Commission Task Force on Safe Work/School/Travel published a very…